Search

everythinglearnresearchcommunity

for

Search:↓

taVNS reduces vitiligo symptoms in mice.

Genetic mutations that disrupt homocysteine breakdown lead to increased damage in mouse hair keratin.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

Pantethine may boost the immune system's ability to fight sarcoma.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

UV light causes skin color loss in bald areas; wear a cap and use sunscreen.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Hair follicles prevent NK cell attacks to avoid hair loss.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Stress might contribute to hair loss in alopecia areata.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Norepinephrine helps skin cells grow, which is important for hair growth.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Stem-cell therapy shows promise for skin conditions but needs more research.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.